271 related articles for article (PubMed ID: 8671981)
1. Membranous nephropathy: recurrence after kidney transplantation.
Marcen R; Mampaso F; Teruel JL; Rivera ME; Orofino L; Navarro-Antolin J; Ortuño J
Nephrol Dial Transplant; 1996 Jun; 11(6):1129-33. PubMed ID: 8671981
[TBL] [Abstract][Full Text] [Related]
2. A case of living-related renal transplant from the donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
Obayashi M; Uzu T; Harada T; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
[TBL] [Abstract][Full Text] [Related]
4. An attempt to extend the donor criteria for successful living-related kidney transplantation from a donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakamoto S; Yoshimura N
Transplant Proc; 2009; 41(1):446-9. PubMed ID: 19249577
[TBL] [Abstract][Full Text] [Related]
5. Recurrent membranous nephropathy and leiomyosarcoma in the renal allograft of a lupus patient.
Ashfaq A; Haller JE; Mossey R; Bellucci A; Miller I; Latcha S; Susin M
J Nephrol; 2004; 17(1):134-8. PubMed ID: 15151271
[TBL] [Abstract][Full Text] [Related]
6. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
8. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of idiopathic membranous nephropathy in a renal allograft.
Crosson JT; Wathen RL; Raij L; Andersen RC; Anderson WR
Arch Intern Med; 1975 Aug; 135(8):1101-6. PubMed ID: 1098595
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant de novo membranous nephropathy in childhood.
Sebire NJ; Bockenhauer D
Fetal Pediatr Pathol; 2005; 24(2):95-103. PubMed ID: 16243754
[TBL] [Abstract][Full Text] [Related]
12. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
14. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
Boratyńska M; Banasik M; Watorek E; Falkiewicz K; Patrzałek D; Szyber P; Klinger M
Transplant Proc; 2006; 38(1):101-4. PubMed ID: 16504675
[TBL] [Abstract][Full Text] [Related]
15. [Membranous glomerulonephritis].
Polenaković M
Srp Arh Celok Lek; 1996; 124 Suppl 1():18-25. PubMed ID: 9102898
[TBL] [Abstract][Full Text] [Related]
16. A primer on recurrent and de novo glomerulonephritis in renal allografts.
Ivanyi B
Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
[TBL] [Abstract][Full Text] [Related]
17. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
[TBL] [Abstract][Full Text] [Related]
18. Rapid recurrence of membranous nephropathy in a related allograft.
Lieberthal W; Bernard DB; Donohoe JF; Stilmant MM; Couser WG
Clin Nephrol; 1979 Nov; 12(5):222-8. PubMed ID: 389508
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of untreated patients with idiopathic membranous nephropathy.
Schieppati A; Mosconi L; Perna A; Mecca G; Bertani T; Garattini S; Remuzzi G
N Engl J Med; 1993 Jul; 329(2):85-9. PubMed ID: 8510707
[TBL] [Abstract][Full Text] [Related]
20. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
